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Objectives This study aims to assess the mid- to long-term follow-up of patients after valve emboli-
zation at the time of transcatheter aortic valve implantation (TAVI).
Background Transcatheter heart valve (THV) embolization is a rare but serious complication during
TAVI. Although various techniques have been developed to manage acute complications and reduce
periprocedural morbidity/mortality, long-term clinical and hemodynamic consequences after these
events are unknown.
Methods Patients who developed THV embolization after TAVI were prospectively assessed. Clinical
and echocardiographic characteristics were recorded at baseline and after successful TAVI/surgical
aortic valve replacement. The THV migration and strut fractures/degeneration were assessed by
computed tomography.
Results A total of 7 patients had THV embolization, all of which occurred immediately after valve
deployment. The embolized THV was repositioned in the aortic arch proximal to the left subclavian
artery (n  2), immediately distal to the left subclavian artery (n  2), and in the abdominal aorta
(n  3). A second THV was implanted successfully at the same sitting in 4 patients and at the time
of a second procedure in 2 patients. Elective conventional aortic valve replacement was performed
in 1 patient. Median follow-up was 1,085 days. One patient died during follow-up from an unrelated
cause. The remaining 6 survivors were in New York Heart Association functional class I or II at ﬁnal
follow-up. Mid-term computed tomography follow-up (n  4,591 to 1,548 days) showed that the
leaﬂets of the embolized THV remain open in all phases of the cardiac cycle. There was also no strut
fracture or migration of these valves.
Conclusions Clinical outcomes remain good when THV embolization is managed effectively. There
are no apparent hemodynamic consequences of a second valve placed in the series. These embo-
lized valves remain in a stable position with no evidence of strut fractures at mid-term follow-up.
(J Am Coll Cardiol Intv 2011;4:228–34) © 2011 by the American College of Cardiology Foundation
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229Embolization of transcatheter aortic valves has been previ-
ously described (1). This rare but important complication
might occur due to poor positioning of the transcatheter
heart valve (THV) or valve ejection after effective ventricular
contraction. The potential causes, acute management, and
management of this complication have been previously
described (2,3). We sought to examine the late outcomes
and implications of valve embolization.
Methods
All patients undergoing transcatheter aortic valve implan-
tation (TAVI) between January 2005 and November 2009
for severe symptomatic aortic stenosis complicated by em-
bolization of the THV were prospectively followed in 2
heart centers. Embolization was considered to have oc-
curred when a THV became freely mobile in the aorta after
attempted implantation in the aortic annulus. In all patients,
TAVI was performed under general anesthesia with trans-
esophageal and fluoroscopic monitoring.
Baseline clinical and procedural characteristics were re-
corded. Transthoracic echocardiography was performed at
baseline, 1 month, 6 months and annually. Follow-up was
performed at clinics, by chart reviews and telephone calls to
patients or their families/physicians. Computed tomogra-
phy (CT), to evaluate the position, structural integrity, and
leaflet function of the embolized THV, was performed at
3 years or earlier if clinically indicated.
Results
Seven patients were identified with THV embolization.
The median age was 82 years (range 71 to 86 years). All
patients were in New York Heart Association functional
class III or III at baseline. The median aortic annulus size
was 22 (20 to 25) mm (Table 1).
In all cases, embolization occurred immediately after
THV deployment. There were no cases of late emboliza-
Table 1. Clinical Characteristics
Case #
Age,
yrs Sex STS Score
NYH
Functi
Cla
Base
1 84 Female 6.4 (porcelain aorta) 3
2 85 Female 8.7 3
3 71 Male 3.8 (left internal mammary graft adherent
to chest wall)
3
4 82 Female 5.1 (frailty) 3
5 86 Male 11.9 3
6 76 Male 3.4 (colonic carcinoma) 3
7 82 Male 10.6 3NYHA New York Heart Association; STS Society of Thoracic Surgeons (parentheses denote unscored ction. Embolization was a feature of the early experience, at
which time the principles of correct positioning and deploy-
ment were not established. All of these cases occurred in the
first half of the experience. There has only been 1 case of
embolization in the latter half of the TAVI experience (i.e.,
6 cases of embolization in the first 150 TAVIs at Vancou-
ver, and 1 in the next 159 patients).
Causes of embolization. The reasons for embolization were
dentifiable in all patients (Table 2). The most common
eason was placing the valve too aortic (Fig. 1) (4 of 7 cases).
his was followed by inadequate visualization of the valve
lane and the inability to recognize that the valve was not
oaxial to the valve plane before deployment (the concept of
erpendicularity of the valve plane was not well-understood
n the early experience; it is now well-established that all 3
inuses of the aorta must lie on a line on fluoroscopy with
he long axis of the valve positioned perpendicular to this
ine to ensure coaxiality). Three cases were caused by
nadequate ventricular pacing (2 occurred from transient
oss of ventricular capture by the pacing lead, and 1 from
remature termination of ventricular pacing) during deploy-
ent of the valve, resulting in an increase in stroke volume
jecting the valve (Fig. 2). Other
auses were less common. Em-
olization in Case #1 occurred
ecause of prior mitral valve re-
lacement surgery: the struts of
he bioprosthesis displaced the
alve-balloon toward the aorta
superiorly) during deployment.
ecause of this, a successful
AVI was performed in this pa-
ient 4 years later with a shorter balloon and a transapical
oute. Case #3 demonstrated the importance of prior bal-
oon aortic valvuloplasty. The operator initially felt that
alloon aortic valvuloplasty was not necessary, because the
alve could be crossed easily and the patient had prior
trokes. This omission made crossing and positioning dif-
Aortic
Valve Area
Baseline Mean
Transaortic
Gradient,
mm Hg
Left
Ventricular
Function, %
Annulus Size,
mm
Valve Size
Selected,
mm
0.6 34 60 22 23
0.9 20 65 22 23
0.6 57 65 22 26
0.3 65 65 22 23
0.7 26 30 25 26
0.6 64 65 20 23
0.6 35 35 23 26
Abbreviations
and Acronyms
CT  computed tomography
TAVI  transcatheter aortic
valve implantation
THV  transcatheter heart
valveA
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230ficult. The valve was partially dislodged while maneuvering
from the balloon and had to be repositioned in the aorta.
Importantly, in all these 7 patients, the Amplatz extra-
stiff exchange length wire (Cook Medical, Bloomington,
Indiana) was kept in place (within the THV) to prevent
inversion of the THV. The deployment balloon was then
reinflated partially within the valve with the balloon shoul-
der as a leading edge to reposition the valve atraumatically.
Most patients (n  6) were discharged without further
n-hospital complications. One patient (Case #4) was noted
Table 2. Causes of Embolization and Final Outcomes
Case #
Reasons for Embolization
Not-Coaxial
to Valve
Plane
Too
Aortic Pacing Others
1 X X (struts of mitral
bioprosthesis displace
the deployment balloo
during inﬂation)
2 X X (premature
termination)
3 X (lack of prior aortic bal
valvuloplasty before T
4 X X
5 X X (loss of capture)
6 X X
7 Inadequate reduction
of pulse pressure
at 160/min
ES Edwards-SAPIEN; NYHA New York Heart Association; TAVI transcatheter aortic valve imp
Figure 1. Fluoroscopic Imaging of the Aortic Root and the Importance of Id
(A) Superior positioning of the transcatheter heart valve (THV) (valve plane is
(C) Final position of both the embolized valve and anatomically placed valve.o have a mobile mass attached to the embolized THV
uggestive of a thrombus. She was anticoagulated, and
ubsequent imaging showed resolution.
Follow-up. Median follow-up was 1,085 days (365 to 1,747
days), at which time 6 of 7 patients remained alive and in
New York Heart Association functional class I or II. One
patient (Case #5) died on day 221 from unrelated compli-
cations of diverticulitis. Another (Case #6) had an asymp-
tomatic, limited dissection of the ascending aorta adjacent
to the embolized THV detected 5 months after the index
Size of Second Valve
Deployed During the
Index Procedure,
mm
Position of
Embolized Valve
Final Management
of Native Valve
NYHA
Functional
Class
(Follow-Up)
Not implanted Transverse aorta Repeat TAVI 4 yrs
later (transapical
23 mm ES valve)
II
23 Distal to left
subclavian artery
Repeat TAVI same
sitting
I
26 Abdominal aorta Repeat TAVI same
sitting
II
23 Abdominal aorta Repeat TAVI same
sitting
II
Not implanted Transverse aorta Repeat TAVI
7 months later
(transapical
26 mm ES valve)
Died
Not implanted Distal to left
subclavian artery
Conventional
aortic valve
replacement
(4 months later)
II
26 Abdominal aorta Repeat TAVI same
sitting
I
n.
ing the Valve Plane
with dashed lines). (B) Repositioning of the valve with the balloon.d
n
loon
AVI)entify
shown
e
w
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231TAVI during conventional aortic valve surgery. The THV
was removed, and the dissection was repaired uneventfully.
Follow-up transthoracic echocardiography after replace-
ment of the anatomical aortic valve (i.e., THV or conven-
tional surgery) showed a significant improvement in aortic
valve area with a concomitant reduction of aortic valve
gradient from baseline. All patients had mild aortic regur-
gitation at follow-up. We were unable to measure echocar-
diographic transvalvular gradients across the embolized
THV positioned in the aorta, with the exception of 1
patient in whom there was no gradient (Case #4).
Computed tomography was performed in 4 patients (at
591 to 1,548 days). There was no evidence of any clinically
significant migration of the embolized THV in these
patients (Fig. 3) on the basis of comparison of the final
fluoroscopic images with follow-up CT. The integrity of
the THV was preserved with no evidence of strut fracture
(Fig. 4). Images of both valves (embolized and anatomically
placed THV) were acquired in both systole and diastole.
Figure 2. Ineffective Ventricular Pacing Resulting in Valve Embolization
Images from Case #7. (A) electrocardiogram and femoral artery pressure tracings
Lower echocardiographic image shows that the valve leaﬂets of the embolized vaThe anatomically placed valves, as expected, were fully open win systole and closed in diastole. However, the embolized
valve leaflets remained in the open position during both
phases of the cardiac cycle in all 4 cases (Figs. 5 and 6). This
is seen in embolized THVs positioned in the proximal or
distal (abdominal aorta).
Discussion
Transcatheter heart valve embolization is a largely but not
entirely preventable complication with current balloon-
expandable valves. We have previously reviewed the factors
that predispose to this complication (3). Attention to
procedural details, optimal imaging, and an improved un-
derstanding of the procedure are making this a relatively
rare occurrence. Currently the published rates of valve
embolization range from 0.5% to 8% (4–8).
Early outcomes. This experience demonstrates that acute
mbolization of balloon-expandable valves can be associated
ith favorable outcomes, if managed appropriately. There
g the lack of adequate reduction in pulse pressure during valve deployment (*).
ains in the open position in systole (B) and diastole (C).showinere no apparent adverse outcomes because of emboliza-
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232tion. When embolization does occur, it is important to have
a good understanding of the how this is best managed.
Maintaining a coaxial wire within the prosthesis prevents it
from becoming inverted and obstructing aortic flow. Repo-
sitioning can be accomplished by withdrawing the THV on
an inflated valvuloplasty balloon to a secure position in the
more distal aorta while avoiding aortic injury. Slight over-
dilation might assist in fixing the THV in an area free of
side-branches. The THVs remains acutely stable in their
position, and there is no adverse effect on hemodynamic
status. In this study, we have not addressed another group of
patients who might have an unstable valve in the left
ventricular outflow tract or even valves that “embolize” into
the left ventricle. Strictly speaking, these should not be
classified as embolization. These valves are often treated
with a variety of techniques: an overlapping second valve to
stabilize the first or inflate a balloon in or distal to the THV
and attempt to retrieve or reposition it. Most patients,
however, still undergo open surgery to remove the THV.
In this experience, 2 patients had the embolized THV
ultimately fixed in the transverse aorta, 2 just distal to the
subclavian artery, and 3 in the descending aorta (Fig. 3).
Experience gained from thoracic endovascular aortic stent
Figure 3. Comparing the Embolized Valve Position at the End of the Proced
Three-dimensional reconstruction of the aorta and the embolized transcathete
verse arch (left), the abdominal aorta (middle), and the aorta distal to the left
the end of the procedure.ure and at Follow-Up
r heart valves (THVs). This shows the position of the THVs implanted in the trans-
subclavian artery (right). Inserts show the ﬂuoroscopic position of the valves atrepair suggests an increased risk of strokes when devices areFigure 4. CT Assessment for Valve Stent Fracture at Follow-Up
Higher magniﬁcation of the transcatheter heart valve (THV) on computed
tomography (CT) to assess for strut fracture.
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233placed proximally or near the arch (9). No periprocedural
strokes were detected in these patients.
The in vivo mechanics of the embolized valve are un-
known. Although valved-stents placed in the descending
aorta of animal models with severe aortic regurgitation
might reduce aortic regurgitation (10,11), it is uncertain
whether this physiology is mirrored in humans.
Implantation of a covered or uncovered stent within an
embolized valve has been suggested. However, this was not
necessary in our experience and might be a source of
needless complications. If the guidewire is maintained
within the THV during repositioning, it will be maintained
oriented in the direction of flow. Our experience suggests
there are no important hemodynamic adverse consequences
Figure 5. CT of the Embolized THV Demonstrating No Hemodynamic Intera
Computed tomography (CT) of the embolized transcatheter heart valve (THV)
images were taken during early diastole. The embolized valve is shown en-fac
arrows). C shows the valve in the aortic root, which is closed during this phas
diastole.
Figure 6. CT of the Embolized THV (Descending Aorta) Showing No Interac
Case #4. Axial computed tomography (CT) images of transcatheter heart valve
position remains closed in early diastole, whereas the embolized THV in the descendof a correctly oriented THV implanted in the aorta. In
contrast, an inverted valve likely would be obstructive,
which might be effectively managed with stenting.
The potential for aortic dissection because of manipulating a
THV in the aorta is an obvious concern. Injury to ascending
aorta was observed in 1 patient, although fortunately this
responded well to conservative management. Atheroembolism
because of aortic injury is likely to occur but was not clinically
evident. Occlusion of an aortic side-branch is similarly a
concern but was not observed. Thrombus formation on the
embolized valve in the descending aorta was observed in 1 case,
although the significance of this is unclear.
Late outcomes. In this study, most patients who underwent
a successful second procedure derived significant benefit
of the 2 Valves in Series
e #2 showing the hemodynamic interaction of the 2 valves in series. All 3
and longitudinally in B, demonstrating that the valves are opened (white
he cardiac cycle. The embolized valve remains open throughout systole and
ith the Anatomically Placed THV
s) in the aortic root (A) and the descending aorta (B). The THV in the aorticction
in Cas
e in A
e of ttion W
s (THV
ing aorta is wide open (black arrows show valve leaﬂets).
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234with improvements in functional class, aortic valve area, and
aortic valve gradients at mid- to long-term follow-up, with
no suggestion of adverse impact of the embolized valve on
outcomes compared with published studies of TAVI pa-
tients (12).
Echocardiography and late CT imaging in 4 patients clearly
showed that the valve leaflets remained in the open position
during systole and diastole (Figs. 5 and 6). This indicates that
the diastolic pressures distal to the valve do not exceed the
proximal pressures and there is no significant diastolic flow
reversal. It seems that (correctly oriented) embolized THVs
functionally behave like a covered stent. Similar findings have
been suggested with CoreValve (Medtronic, Inc., Irvine, Cal-
ifornia) self-expanding prostheses implanted in the descending
aorta (13).
Late migration of THVs was not observed. In this series,
THVs were withdrawn to a portion of the aorta with a
diameter that approximated the THV diameter. At this point,
the THV was slightly over-dilated. Late movement might still
occur in cases where a THV could not be manipulated into a
secure position. A limitation of this study is the lack of CT
done immediately after the procedure for comparison with the
follow-up CT. The comparison of fluoroscopic imaging and
CT is not optimal, but no clinical significance was seen.
Currently available balloon-expandable valve frames are
designed to be resistant to fracture or structural failure.
Stents implanted within the aorta are not subject to the
forces seen with implantation in the heart itself. It is
reassuring that stent fracture was not observed on late CT
imaging.
Prevention is better than cure. Although embolization can
be managed effectively in the acute situation and seems to
have good outcomes, prevention remains the key to success.
Meticulous attention must be paid to accurately size the
valve, derive an optimal plane perpendicular to the valve,
and ensure reliable control of ventricular pacing before valve
deployment.
Conclusions
Embolization of balloon-expandable valves is a rare acute
complication of TAVI but can be managed effectively with
good early outcomes. Embolized valves oriented correctly inthe direction of flow did not seem to have hemodynamic
consequences. When repositioned in the aorta, adverse
clinical consequences were not observed at late follow-up.
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